Developing precision computerised cognitive behavioural therapy for adolescent depression: a pilot and feasibility randomised controlled trial (SPARX-UK)

niversity of Nottingham0 sites120 target enrollmentJanuary 16, 2023

Overview

2024 Protocol article in https://pubmed.ncbi.nlm.nih.gov/38532490/ (added 27/03/2024)

Registry

who.int

Start Date

January 16, 2023

End Date

March 30, 2025

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

niversity of Nottingham

•1\. Adolescents aged 11 to 19 years on the date of consent referred to CAMHS or MHST
•2\. Presented at CAMHS/MHST for treatment with symptoms indicative of mild to moderate depressive disorder as confirmed by the PHQ\-A
•3\. Able to provide written consent or, if under age 16, written parental consent and written/verbal child assent
•4\. Has access to a computer with internet access or smartphone or device to use SPARX and must be able to install and log in
•5\. Parent and adolescent able to read and write in English

•1\. Depression assessed as being too severe to make SPARX an appropriate intervention as confirmed by the PHQ\-A
•2\. High risk of current self\-harm or suicide as confirmed by a clinician
•3\. Intellectual disability or physical limitations precluding the use of SPARX
•4\. Had (in the past three months) or currently having treatment with CBT/interpersonal therapy
•5\. Has another major mental health disorder (e.g., psychosis, eating disorder) where the primary focus was not depression as confirmed by a clinician or DAWBA
•6\. Safeguarding concerns that are currently not being managed (i.e., the young person is the subject of a safeguarding investigation) as confirmed by a clinician